SCHEMBL24364266

SCHEMBL24364266

c1cc([C@@H]2CCCCN2)ccn1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 3/20 0.66
CHRNA4 P43681 3/20 0.66
MEN1 O00255 2/20 0.66
CYP2D6 P10635 2/20 0.66
CYP2C19 P33261 2/20 0.66
KMT2A Q03164 2/20 0.66
CHRNA7 P36544 2/20 0.66
POLB P06746 1/20 0.66
SMN1; SMN2 Q16637 1/20 0.66
CYP1A2 P05177 1/20 0.66
CYP2A6 P11509 1/20 0.66
CYP2C9 P11712 1/20 0.66
AURKA O14965 1/20 0.47
MKNK1 Q9BUB5 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.40
MAPKAPK2 P49137 1/20 0.39
KCNH2 Q12809 1/20 0.39
RECQL P46063 1/20 0.39
PARP1 P09874 1/20 0.39
PARP2 Q9UGN5 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7134733 1.00 CHRNB2 (0.66) CHRNB2CHRNA4MEN1CYP2D6CYP2C19
SCHEMBL28233502 1.00 CHRNB2 (0.66) CHRNB2CHRNA4MEN1CYP2D6CYP2C19
Hydrochloric Acid SCHEMBL29688629 0.98 CHRNB2 (0.64) CHRNB2CHRNA4MEN1CYP2D6CYP2C19
SCHEMBL10648778 0.98 CHRNB2 (0.64) CHRNB2CHRNA4MEN1CYP2D6CYP2C19
SCHEMBL13100347 0.94 CHRNB2 (0.65) CHRNB2CHRNA4MEN1CYP2D6CYP2C19
SCHEMBL168915 0.94 CHRNB2 (0.65) CHRNB2CHRNA4MEN1CYP2D6CYP2C19
Pyridine SCHEMBL27552784 0.85 CHRNB2 (0.73) CHRNB2CHRNA4MEN1CYP2D6CYP2C19
Acetic Acid SCHEMBL28811721 0.83 CHRNB2 (0.53) CHRNB2CHRNA4MEN1CYP2D6CYP2C19
SCHEMBL20449140 0.81 CHRNB2 (0.62) CHRNB2CHRNA4MEN1CYP2D6CYP2C19
SCHEMBL20449139 0.81 CHRNB2 (0.62) CHRNB2CHRNA4MEN1CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228478-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2024-07-11 US disclosed
US-20220127256-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2022-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127256-A1 COMPOUNDS AND METHODS OF USE F12, C1R, ABCG2 CHRNB2 3217/4885CHRNA4 2950/4885MEN1 142/4885
US-20240228478-A1 COMPOUNDS AND METHODS OF USE F12, C1R, ABCG2 CHRNB2 3217/4885CHRNA4 2950/4885MEN1 142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.